Patents by Inventor Jason Charles O'NEILL

Jason Charles O'NEILL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
    Publication number: 20240010708
    Abstract: There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: August 28, 2023
    Publication date: January 11, 2024
    Applicant: AMGEN INC.
    Inventors: Jeonghoon SUN, Jason Charles O'NEILL, Randal R. KETCHEM, Randy Ira HECHT, Edward J. BELOUSKI, Mark Leo MICHAELS
  • BCMA antigen binding proteins
    Patent number: 10465009
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: November 5, 2019
    Assignee: Amgen Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko, Zhulun Wang, Athena Sudom
  • VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
    Publication number: 20190085054
    Abstract: There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: December 4, 2018
    Publication date: March 21, 2019
    Inventors: Jeonghoon Sun, Jason Charles O'Neill, Randal R. Ketchem, Randy Ira Hecht, Edward J. Belouski, Mark Leo Michaels
  • BCMA Antigen binding proteins
    Patent number: 10220090
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: March 5, 2019
    Assignee: Amgen Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko
  • Variants of tissue inhibitor of metalloproteinase type three (TIMP-3), compositions and methods
    Patent number: 10189890
    Abstract: There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: January 29, 2019
    Assignee: Amgen Inc.
    Inventors: Jeonghoon Sun, Jason Charles O'Neill, Randal R. Ketchem, Randy Ira Hecht, Edward J. Belouski, Mark Leo Michaels
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20190008974
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 11, 2015
    Publication date: January 10, 2019
    Applicant: Amgen Inc.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20170165373
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 11, 2015
    Publication date: June 15, 2017
    Applicant: Amgen Inc.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO
  • VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
    Publication number: 20160031969
    Abstract: There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: March 13, 2014
    Publication date: February 4, 2016
    Applicant: AMGEN INC.
    Inventors: Jeonghoon Sun, Jason Charles O'Neill, Randal R. Ketchem, Randy Ira Hecht, Edward J. Belouski, Mark Leo Michaels
  • BCMA antigen binding proteins
    Patent number: 9243058
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: January 26, 2016
    Assignee: Amgen, Inc.
    Inventors: Richard J. Armitage, Michelle Blake, William C. Fanslow, III, Jason Charles O'Neill, Gunasekaran Kannan, Jiangchun Xu, Mark Edward Tometsko
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20150344583
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates and uses thereof.
    Type: Application
    Filed: December 5, 2013
    Publication date: December 3, 2015
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO, Zhulun WANG, Athena SUDOM
  • VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS
    Publication number: 20140274874
    Abstract: There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: AMGEN INC.
    Inventors: Randal R. KETCHEM, Jason Charles O'NEILL, Jeonghoon SUN
  • BCMA ANTIGEN BINDING PROTEINS
    Publication number: 20140161828
    Abstract: The present invention relates to BCMA (B-Cell Maturation Antigen) antigen binding proteins, such as antibodies, polynucleotide sequences encoding said antigen binding proteins, and compositions and methods for diagnosing and treating diseases. The present invention also relates to BCMA antibody drug conjugates.
    Type: Application
    Filed: December 5, 2013
    Publication date: June 12, 2014
    Applicant: AMGEN INC.
    Inventors: Richard J. ARMITAGE, Michelle BLAKE, William C. FANSLOW, III, Jason Charles O'NEILL, Gunasekaran KANNAN, Jiangchun XU, Mark Edward TOMETSKO